Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med (New York, N.Y.)
View this publicationMed (New York, N.Y.)
View this publicationBiology
View this publicationThe Journal of allergy and clinical immunology
View this publicationThe Journal of neuroscience : the official journal of the Society for Neuroscience
View this publicationJACC. Cardiovascular interventions
View this publicationJournal of clinical medicine
View this publicationJournal of genetics and genomics = Yi chuan xue bao
View this publicationThe Journal of clinical investigation
View this publicationCurrent oncology (Toronto, Ont.)
View this publicationAllergy
View this publication